Rock Creek Pharmaceuticals, Inc. announced earnings results for the year ended December 31, 2015. For the year, the company reported a net loss from continuing operations of approximately $6.8 million compared to a net loss from continuing operations of approximately $33.1 million in 2014, a reduction in losses of $26.3 million. The reduction in the net loss was attributable to the reduced expenses as a result of the restructuring involving consolidation of offices, reduction in headcount, a reduction in non-cash share-based compensation and lower legal expenses.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2020 | Rock Creek Pharmaceuticals, Inc. Went Out of Business | CI |
2020 | Bankruptcy Judge Changed for Rock Creek Pharmaceuticals, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 17.04K | |
+33.21% | 704B | |
+28.59% | 577B | |
-3.73% | 348B | |
+18.70% | 327B | |
+4.49% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.11% | 147B |
- Stock Market
- Equities
- RCPIQ Stock
- News Rock Creek Pharmaceuticals, Inc.
- Rock Creek Pharmaceuticals, Inc. Announces Earnings Results for the Year Ended December 31, 2015